Citrate, Toremifene,
Fareston,
FC 1157a,
FC-1157a,
FC1157a,
Toremifene,
Toremifene Citrate,
Toremifene Citrate (1:1),
Toremifene, (E)-Isomer,
TOREMIFENE CITRATE,
89778-27-8,
Fareston,
Toremifene (Citrate),
FC 1157a,
Toremifene citrate [USAN],
NK 622,
NSC 613680,
CCRIS 6719,
UNII-2498Y783QT,
NSC613680,
2498Y783QT,
CPD000469213,
Toremifene Citrate (Fareston, Acapodene),
DSSTox_CID_1367,
(Z)-4-Chloro-1,2-diphenyl-1-(4-(2-(N,N-dimethylamino)ethoxy)phenyl)-1-butene citrate (1:1),
2-(p-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1),
DSSTox_RID_76113,
DSSTox_GSID_21367,
2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; citric acid,
2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt),
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid,
Ethanamine, 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1),
CAS-89778-27-8,
citro; toremifene,
2-[p-[(Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethylamine citrate (1:1),
Fareston;Acapodene,
AC1Q5SNQ,
AC1MHJ30,
SCHEMBL4564,
Toremifene-Citrate(Fareston),
MLS001306432,
MLS006011608,
CHEBI:9636,
CHEMBL1200675,
DTXSID2021367,
Toremifene citrate (JAN/USAN),
IWEQQRMGNVVKQW-OQKDUQJOSA-N,
HMS2052C03,
HMS2230P09,
HMS3264L11,
Pharmakon1600-01505682,
HY-B0005,
Tox21_111877,
Tox21_301740,
BG0531,
KM2865,
MFCD01729016,
NSC759190,
s1776,
AKOS015888270,
AC-1985,
CCG-101072,
CS-1272,
KS-5242,
NC00322,
NSC-613680,
NSC-759190,
2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1),
NCGC00255310-01,
AK139145,
AN-14397,
BC215662,
LS-64922,
S962,
SAM001246774,
SMR004703372,
Toremifene citrate salt, >=98% (HPLC),
AB2000287,
TL8005784,
ST24050182,
SW197702-3,
D00967,
778T267,
A843307,
I01-1039,
SR-01000763502-3,
2-[p-[(Z)-4-chloro-1,N- dimethylethylamine citrate (1:1),
(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine Citrate,
(Z)-2-[4-(4-chloro-1,N- dimethylethanamine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1),
(Z)-4-Chloro-1-(4-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate,
(Z)-2-(4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate,
(Z)-2-(4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate,
(Z)-2-(4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate,
(Z)-4-Chloro-1-(4-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate / (Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine Citrate,
2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate(1:1),
2-[4-[(Z)-4-chloranyl-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; 2-oxidanylpropane-1,2,3-tricarboxylic acid,
2-{4-[4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt),
Acapodene,
toremifene,
Fareston (TN),
C32H36ClNO8,
TOREMIPHENE CITRATE,
FC-1157a,
MLS001424189,
C26H28ClNO.C6H8O7,
89778-27-8 (citrate),
CID3005572,
NCGC00160530-01,
C26-H28-Cl-N-O.C6-H8-O7,
SMR000469213,
B1513,
T2832,
SR-01000763502,
89778-26-7,